Antibodies
|
Controls n = 309
|
Pre-RA n = 103
|
Crude
|
Fully adjusted model
|
---|
|
n (%)
|
n (%)
|
OR (95 % CI)
|
p-value
|
OR (95 % CI)a
|
p-value
|
---|
CCP2
|
10 (3)
|
24 (23)
|
9.94 (4.28–23.07)
|
<0.001
|
9.46 (3.89–23.00)
|
<0.001
|
RF
|
12 (4)
|
23 (22)
|
5.73 (2.79–11.76)
|
<0.001
|
5.84 (2.66–12.86)
|
<0.001
|
CEP1
|
6 (2)
|
15 (15)
|
7.11 (2.75–18.35)
|
<0.001
|
7.26 (2.53–20.82)
|
<0.001
|
REP1
|
6 (2)
|
2 (2)
|
0.77 (0.15–3.93)
|
0.748
|
1.17 (0.22–6.30)
|
0.853
|
cFIB
|
5 (2)
|
8 (18)
|
12.01 (4.06–35.55)
|
<0.001
|
10.44 (3.39–32.10)
|
<0.001
|
FIB
|
5 (2)
|
2 (2)
|
1.00 (0.19–5.19)
|
1.000
|
1.05 (0.20–0.57)
|
0.957
|
cVIM
|
3 (2)
|
5 (6)
|
2.84 (0.66–12.05)
|
0.157
|
4.84 (0.94–24.94)
|
0.059
|
VIM
|
5 (2)
|
4 (4)
|
2.00 (0.53–7.50)
|
0.304
|
2.47 (0.62–9.76)
|
0.199
|
CPP3
|
6 (2)
|
2 (2)
|
1.00 (0.20–4.95)
|
1.000
|
1.54 (0.28–8.31)
|
0.618
|
RPP3
|
5 (2)
|
5 (5)
|
2.88 (0.83–9.97)
|
0.095
|
3.76 (0.89–15.86)
|
0.071
|
CPP5
|
6 (2)
|
5 (5)
|
2.41 (0.73–7.91)
|
0.147
|
2.47 (0.71–8.54)
|
0.154
|
RPP5
|
5 (2)
|
2 (2)
|
1.20 (0.23–6.19)
|
0.827
|
1.78 (0.31–10.39)
|
0.521
|
RgpB
|
12 (4)
|
3 (3)
|
0.66 (0.17–2.62)
|
0.555
|
0.60 (0.15–2.46)
|
0.479
|
RGPB categories
|
1 (<1280)
|
123 (44)
|
51 (50)
|
ref
|
-
|
ref
|
-
|
2 (≥1280)
|
75 (27)
|
29 (28)
|
0.93 (0.54–1.60)
|
0.787
|
0.98 (0.55–1.77)
|
0.957
|
3 (≥2560)
|
68 (24)
|
20 (19)
|
0.74 (0.39–1.38)
|
0.341
|
0.85 (0.44–1.68)
|
0.647
|
4 (≥5120)
|
12 (4)
|
3 (3)
|
0.59 (0.14–2.45)
|
0.472
|
0.57 (0.13–2.44)
|
0.449
|
-
a Adjusted for BMI, waist circumference, smoking, education, physical activity, and alcohol intake